Dihydrotachysterol

Dihydrotachysterol

File:Dihydrotachysterol.svg
Clinical data
ATC code	A11CC02 (WHO)
Pharmacokinetic data
Protein binding	>99%
Identifiers
IUPAC name 3-[2-[7a-methyl-1- (1,4,5-trimethylhex-2-enyl)- 1,2,3,3a,5,6,7,7a- octahydroinden-4-ylidene] ethylidene]- 4-methyl-cyclohexan-1-ol
CAS Number	67-96-9
PubChem CID	5281010
DrugBank	APRD00143
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C28H46O
Molar mass	398.664 g/mol

WikiDoc Resources for Dihydrotachysterol
Articles
Most recent articles on Dihydrotachysterol Most cited articles on Dihydrotachysterol Review articles on Dihydrotachysterol Articles on Dihydrotachysterol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dihydrotachysterol Images of Dihydrotachysterol Photos of Dihydrotachysterol Podcasts & MP3s on Dihydrotachysterol Videos on Dihydrotachysterol
Evidence Based Medicine
Cochrane Collaboration on Dihydrotachysterol Bandolier on Dihydrotachysterol TRIP on Dihydrotachysterol
Clinical Trials
Ongoing Trials on Dihydrotachysterol at Clinical Trials.gov Trial results on Dihydrotachysterol Clinical Trials on Dihydrotachysterol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dihydrotachysterol NICE Guidance on Dihydrotachysterol NHS PRODIGY Guidance FDA on Dihydrotachysterol CDC on Dihydrotachysterol
Books
Books on Dihydrotachysterol
News
Dihydrotachysterol in the news Be alerted to news on Dihydrotachysterol News trends on Dihydrotachysterol
Commentary
Blogs on Dihydrotachysterol
Definitions
Definitions of Dihydrotachysterol
Patient Resources / Community
Patient resources on Dihydrotachysterol Discussion groups on Dihydrotachysterol Patient Handouts on Dihydrotachysterol Directions to Hospitals Treating Dihydrotachysterol Risk calculators and risk factors for Dihydrotachysterol
Healthcare Provider Resources
Symptoms of Dihydrotachysterol Causes & Risk Factors for Dihydrotachysterol Diagnostic studies for Dihydrotachysterol Treatment of Dihydrotachysterol
Continuing Medical Education (CME)
CME Programs on Dihydrotachysterol
International
Dihydrotachysterol en Espanol Dihydrotachysterol en Francais
Business
Dihydrotachysterol in the Marketplace Patents on Dihydrotachysterol
Experimental / Informatics
List of terms related to Dihydrotachysterol

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Dihydrotachysterol (DHT) is a synthetic vitamin D analog activated in the liver that does not require renal hydroxylation like vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on mineralization of bone salts than does vitamin D.